» Articles » PMID: 30233251

Importance of Tumor Location and Histology in Familial Risk of Upper Gastrointestinal Cancers: a Nationwide Cohort Study

Overview
Journal Clin Epidemiol
Publisher Dove Medical Press
Specialty Public Health
Date 2018 Sep 21
PMID 30233251
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Familial clustering of upper gastrointestinal (UGI) cancers and the significance of family history has been addressed previously. We aimed to elucidate the familial risk based on the specified tumor location and histology.

Method: In the Swedish Family-Cancer Database, we determined the familial risk of UGI cancer patients diagnosed (1958-2015) with esophageal and gastric cancer by tumor location using standardized incidence ratios (SIRs).

Results: Risk of esophageal cancer in first-degree relatives (FDRs) of patients with esophageal cancer increased 2.4-fold (SIR 95% CI 2.0-2.8), whereas risk of esophageal cancer in cases with family history of cancer in the middle third of the esophagus increased 3.4-fold (SIR 95% CI 2.1-5.1). Risk of gastric cancer in FDRs increased 1.6-fold (SIR 95% CI 1.5-1.7), occurrence of concordant subsite gastric cancer in the antrum, body, and cardia was 5.5-fold (SIR 95% CI 2.4-11), 4.6-fold (SIR 95% CI 2.6-7.4), and 1.7-fold (SIR 95% CI 1.1-2.5), respectively. Familial risk of concordant histological subtype in esophageal cancer was 4.1-fold for squamous cell carcinoma (SIR 95% CI 3.2-5.2) and 3.6-fold for adenocarcinoma (SIR 95% CI 2.5-5.1). The risk of concordant gastric adenocarcinoma was 1.6-fold for one affected FDR (SIR 95% CI 1.5-1.7), 6.1-fold for two FDRs (SIR 95% CI 4.4-8.4), and 8.6-fold among twins (SIR 95% CI 2.3-22).

Conclusion: Family history of cancer in the lower third of the esophagus and stomach cancer in specific locations such as the antrum, body, and cardia can be considered as important predictive evidence for cancer in the same location in relatives. Our findings might guide endoscopy-based surveillance by introducing subgroups of populations with a higher risk for UGI cancer with particular attention to concordance of location of lesions, which could be a reasonable strategy for early detection, and thus help save more lives.

Citing Articles

Prevalence of in Non-Cardia Gastric Cancer in China: A Systematic Review and Meta-Analysis.

Lu Y, Xiao F, Wang Y, Wang Z, Liu D, Hong F Front Oncol. 2022; 12:850389.

PMID: 35592678 PMC: 9111517. DOI: 10.3389/fonc.2022.850389.


Familial Risks and Proportions Describing Population Landscape of Familial Cancer.

Hemminki K, Sundquist K, Sundquist J, Forsti A, Hemminki A, Li X Cancers (Basel). 2021; 13(17).

PMID: 34503195 PMC: 8430802. DOI: 10.3390/cancers13174385.


Preferences of first-degree relatives of gastric cancer patients for gastric cancer screening: a discrete choice experiment.

Li H, Xue H, Yuan H, Wan G, Zhang X BMC Cancer. 2021; 21(1):959.

PMID: 34445987 PMC: 8393792. DOI: 10.1186/s12885-021-08677-9.


Systematic review with meta-analysis: the effects of family history on the risk of Barrett's oesophagus and oesophageal adenocarcinoma.

Peters Y, van Grinsven E, Siersema P Aliment Pharmacol Ther. 2021; 54(7):868-879.

PMID: 34383966 PMC: 9292032. DOI: 10.1111/apt.16558.


Family History and Gastric Cancer Risk: A Pooled Investigation in the Stomach Cancer Pooling (STOP) Project Consortium.

Vitelli-Storelli F, Rubin-Garcia M, Pelucchi C, Benavente Y, Bonzi R, Rota M Cancers (Basel). 2021; 13(15).

PMID: 34359744 PMC: 8345354. DOI: 10.3390/cancers13153844.


References
1.
Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M . Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2014; 136(5):E359-86. DOI: 10.1002/ijc.29210. View

2.
Hansen S, Vollset S, Derakhshan M, Fyfe V, Melby K, Aase S . Two distinct aetiologies of cardia cancer; evidence from premorbid serological markers of gastric atrophy and Helicobacter pylori status. Gut. 2007; 56(7):918-25. PMC: 1994366. DOI: 10.1136/gut.2006.114504. View

3.
Hemminki K, Ji J, Brandt A, Mousavi S, Sundquist J . The Swedish Family-Cancer Database 2009: prospects for histology-specific and immigrant studies. Int J Cancer. 2009; 126(10):2259-67. DOI: 10.1002/ijc.24795. View

4.
Choi I . Endoscopic gastric cancer screening and surveillance in high-risk groups. Clin Endosc. 2014; 47(6):497-503. PMC: 4260096. DOI: 10.5946/ce.2014.47.6.497. View

5.
Dhillon P, Farrow D, Vaughan T, Chow W, Risch H, Gammon M . Family history of cancer and risk of esophageal and gastric cancers in the United States. Int J Cancer. 2001; 93(1):148-52. DOI: 10.1002/ijc.1294. View